These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 17021816)

  • 81. The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents.
    Mukai H; Wada Y; Watanabe Y
    Ann Nucl Med; 2013 Aug; 27(7):625-39. PubMed ID: 23605059
    [TBL] [Abstract][Full Text] [Related]  

  • 82. 64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation.
    Rossin R; Pan D; Qi K; Turner JL; Sun X; Wooley KL; Welch MJ
    J Nucl Med; 2005 Jul; 46(7):1210-8. PubMed ID: 16000291
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Apoptosis-detecting radioligands: current state of the art and future perspectives.
    Lahorte CM; Vanderheyden JL; Steinmetz N; Van de Wiele C; Dierckx RA; Slegers G
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):887-919. PubMed ID: 15138718
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Biological comparison of 149Pm-, 166Ho-, and 177Lu-DOTA-biotin pretargeted by CC49 scFv-streptavidin fusion protein in xenograft-bearing nude mice.
    Lewis MR; Zhang J; Jia F; Owen NK; Cutler CS; Embree MF; Schultz J; Theodore LJ; Ketring AR; Jurisson SS; Axworthy DB
    Nucl Med Biol; 2004 Feb; 31(2):213-23. PubMed ID: 15013487
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine.
    Ahlgren S; Wållberg H; Tran TA; Widström C; Hjertman M; Abrahmsén L; Berndorff D; Dinkelborg LM; Cyr JE; Feldwisch J; Orlova A; Tolmachev V
    J Nucl Med; 2009 May; 50(5):781-9. PubMed ID: 19372467
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Radioimmunodetection of membrane type-1 matrix metalloproteinase relevant to tumor malignancy with a pre-targeting method.
    Sano K; Temma T; Kuge Y; Kudo T; Kamihashi J; Zhao S; Saji H
    Biol Pharm Bull; 2010; 33(9):1589-95. PubMed ID: 20823579
    [TBL] [Abstract][Full Text] [Related]  

  • 87. In vivo imaging of radiation-induced tissue apoptosis by (99m)Tc(I)-his (6)-annexin A5.
    Lin KJ; Wu CC; Pan YH; Chen FH; Fu SY; Chiang CS; Hong JH; Lo JM
    Ann Nucl Med; 2012 Apr; 26(3):272-80. PubMed ID: 22278351
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Biodistribution and dosimetry study of 123I-rh-annexin V in mice and humans.
    Lahorte CM; van de Wiele C; Bacher K; van den Bossche B; Thierens H; van Belle S; Slegers G; Dierckx RA
    Nucl Med Commun; 2003 Aug; 24(8):871-80. PubMed ID: 12869819
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.
    Kemerink GJ; Liu X; Kieffer D; Ceyssens S; Mortelmans L; Verbruggen AM; Steinmetz ND; Vanderheyden JL; Green AM; Verbeke K
    J Nucl Med; 2003 Jun; 44(6):947-52. PubMed ID: 12791824
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants.
    Wilbur DS; Park SI; Chyan MK; Wan F; Hamlin DK; Shenoi J; Lin Y; Wilbur SM; Buchegger F; Pantelias A; Pagel JM; Press OW
    Bioconjug Chem; 2010 Jul; 21(7):1225-38. PubMed ID: 20597486
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Increased streptavidin uptake in tumors pretargeted with biotinylated antibody using a conjugate of streptavidin-fab fragment.
    Yao Z; Zhang M; Sakahara H; Saga T; Kobayashi H; Nakamoto Y; Toyama S; Konishi J
    Nucl Med Biol; 1998 Aug; 25(6):557-60. PubMed ID: 9751423
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Potential of three-step pretargeting radioimmunotherapy using biotinylated bevacizumab and succinylated streptavidin in triple-negative breast cancer xenograft.
    Gu W; Yudistiro R; Hanaoka H; Katsumata N; Tsushima Y
    Ann Nucl Med; 2021 Apr; 35(4):514-522. PubMed ID: 33582981
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Radiolabeled Cationic Peptides for Targeted Imaging of Infection.
    Aweda TA; Muftuler ZFB; Massicano AVF; Gadhia D; McCarthy KA; Queern S; Bandyopadhyay A; Gao J; Lapi SE
    Contrast Media Mol Imaging; 2019; 2019():3149249. PubMed ID: 32063807
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Tumor-specific detection of an optically targeted antibody combined with a quencher-conjugated neutravidin "quencher-chaser": a dual "quench and chase" strategy to improve target to nontarget ratios for molecular imaging of cancer.
    Ogawa M; Kosaka N; Choyke PL; Kobayashi H
    Bioconjug Chem; 2009 Jan; 20(1):147-54. PubMed ID: 19072537
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Secretion of Recombinant Human Annexin V in Fusion with the Super Folder GFP for Labelling Phosphatidylserine-Exposing Membranes.
    Twair A; Kassem I; Murad H; Abbady AQ
    J Membr Biol; 2021 Apr; 254(2):175-187. PubMed ID: 33604692
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Longitudinal PET imaging of doxorubicin-induced cell death with 18F-Annexin V.
    Hu S; Kiesewetter DO; Zhu L; Guo N; Gao H; Liu G; Hida N; Lang L; Niu G; Chen X
    Mol Imaging Biol; 2012 Dec; 14(6):762-70. PubMed ID: 22392643
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Bifunctional phage-based pretargeted imaging of human prostate carcinoma.
    Newton-Northup JR; Figueroa SD; Quinn TP; Deutscher SL
    Nucl Med Biol; 2009 Oct; 36(7):789-800. PubMed ID: 19720291
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Rapid Imaging of Tumor Cell Death In Vivo Using the C2A Domain of Synaptotagmin-I.
    Neves AA; Xie B; Fawcett S; Alam IS; Witney TH; de Backer MM; Summers J; Hughes W; McGuire S; Soloviev D; Miller J; Howat WJ; Hu DE; Rodrigues TB; Lewis DY; Brindle KM
    J Nucl Med; 2017 Jun; 58(6):881-887. PubMed ID: 28209913
    [TBL] [Abstract][Full Text] [Related]  

  • 99. In vivo detection and imaging of phosphatidylserine expression during programmed cell death.
    Blankenberg FG; Katsikis PD; Tait JF; Davis RE; Naumovski L; Ohtsuki K; Kopiwoda S; Abrams MJ; Darkes M; Robbins RC; Maecker HT; Strauss HW
    Proc Natl Acad Sci U S A; 1998 May; 95(11):6349-54. PubMed ID: 9600968
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.